Related Experiment Video
Updated: Dec 17, 2025

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
Published on: June 20, 2017
Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction
Ernesto Solis1, Kevin N Hascup1,2,3, Erin R Hascup1,2
1Department of Neurology, Neuroscience Institute, Center for Alzheimer's Disease and Related Disorders, Southern Illinois University School of Medicine, Springfield, IL, USA.
Insights
Alzheimer's disease (AD) involves vascular issues like reduced cerebral blood flow (CBF) and blood-brain barrier damage, which precede amyloid-β plaque buildup. These vascular defects significantly contribute to AD progression and neurodegeneration.
Area of Science:
- Neuroscience
- Vascular Biology
- Alzheimer's Disease Research
Background:
- The amyloid cascade hypothesis is central to Alzheimer's disease (AD) pathology.
- Emerging evidence highlights the significant role of vascular dysfunction in AD progression.
- Vascular deficits, including reduced cerebral blood flow (CBF), precede hallmark AD pathologies like amyloid-β (Aβ) plaque accumulation.
Purpose of the Study:
- To review Alzheimer's disease vascular disturbances linked to amyloid-β.
- To emphasize the impact of Aβ on cerebral blood flow and neurovascular coupling.
- To discuss findings on the interplay between vascular defects and Aβ accumulation.
Main Methods:
- Review of existing literature on Alzheimer's disease and vascular pathology.
- Focus on in vivo studies utilizing rodent AD models.
- Analysis of Aβ effects on cerebral blood flow and neurovascular coupling.
Main Results:
- Vascular dysfunction, including chronic cerebral hypoperfusion and hypertension, is evident in AD.
- Amyloid-β impacts cerebral blood flow and neurovascular coupling.
- Deterioration of the blood-brain barrier is a key feature of AD vascular pathology.
Conclusions:
- Vascular disturbances are integral to Alzheimer's disease pathogenesis, not merely a consequence.
- Understanding the relationship between vascular health and Aβ is crucial for AD treatment strategies.
- Rodent AD models provide valuable insights into in vivo vascular changes associated with Aβ.
Abstract:
While prevailing evidence supports that the amyloid cascade hypothesis is a key component of Alzheimer's disease (AD) pathology, many recent studies indicate that the vascular system is also a major contributor to disease progression. Vascular dysfunction and reduced cerebral blood flow (CBF) occur prior to the accumulation and aggregation of amyloid-β (Aβ) plaques and hyperphosphorylated tau tangles. Although research has predominantly focused on the cellular processes involved with Aβ-mediated neurodegeneration, effects of Aβ on CBF and neurovascular coupling are becoming more evident. This review will describe AD vascular disturbances as they relate to Aβ, including chronic cerebral hypoperfusion, hypertension, altered neurovascular coupling, and deterioration of the blood-brain barrier. In addition, we will describe recent findings about the relationship between these vascular defects and Aβ accumulation with emphasis on in vivo studies utilizing rodent AD models.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Neural Regulation
Alzheimer's Disease: Treatment
The Blood-brain Barrier

